INCY

Incyte Corporation Press Releases

$50.825
*  
0.095
0.19%
Get INCY Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading INCY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Incyte Achieves $25 Million Milestone for Approval of Jakavi® (ruxolitinib) in Japan
7/8/2014 7:33:00 AM - Business Wire

Incyte to Present at the 9th Annual JMP Securities Healthcare Conference
6/12/2014 8:00:00 AM - Business Wire

Pivotal Phase III Data in Polycythemia Vera Show that Jakafi® (ruxolitinib) Achieved Superior Disease Control Compared to Best Available Therapies
6/3/2014 10:45:00 AM - Business Wire

Incyte Announces Preliminary Results of a Phase I/II Study of Combination Immunotherapy in Patients with Melanoma
6/2/2014 2:15:00 PM - Business Wire

Incyte Announces Full Results from Proof-of-Concept Phase II RECAP Trial of Jakafi® (ruxolitinib) in Combination with Capecitabine in Patients with Metastatic Pancreatic Cancer
6/2/2014 2:15:00 PM - Business Wire

New Data for Multiple Incyte Cancer Programs to Be Presented at the 2014 American Society of Clinical Oncology (ASCO) Meeting
5/28/2014 7:00:00 AM - Business Wire

Bristol-Myers Squibb and Incyte Enter Clinical Collaboration Agreement to Evaluate Combination Regimen of Two Novel Immunotherapies
5/27/2014 7:00:00 AM - Business Wire

Incyte to Present at Upcoming Investor Conferences
5/20/2014 8:00:00 AM - Business Wire

Incyte and MedImmune Announce Collaboration on Immuno-Oncology Combination Clinical Trial
5/14/2014 2:00:00 AM - Business Wire

Technical Data on Biotech Stocks -- Research on Exact Sciences, Amgen, Exelixis, and Incyte
5/6/2014 9:57:00 AM - PR Newswire

Incyte to Present at Upcoming Investor Conferences
5/2/2014 8:00:00 AM - Business Wire

Incyte Reports 2014 First-Quarter Financial Results and Updates Shareholders on Key Clinical Programs
5/1/2014 7:00:00 AM - Business Wire

Incyte to Report First Quarter 2014 Financial Results on May 1
4/16/2014 8:00:00 AM - Business Wire

Technical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte, Merrimack Pharma, and Aastrom Biosciences
4/14/2014 9:00:00 AM - PR Newswire